Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.
News May 02, 2013
Gore has agreed to take a limited royalty-bearing license under U.S. Patent Nos. 7,293,744 and 7,927,316 and U.S. Reissue No. RE41,169, and their counterparts internationally in connection with its STA-PURE Fluid Sampling Systems and assemblies, Crimp and Cut tools, and STA-PURE Single Use Valve Systems and assemblies.
"Our customers rely on us to be technology leaders for innovation in biopharmaceutical production and, as such, Merck Millipore will continue to vigorously defend its intellectual property," said Andrew Bulpin, Executive Vice President for Merck Millipore Process Solutions.
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of LondonNews
The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.READ MORE
A New Tactic in the Fight Against Drug-Resistant InfectionsNews
$1 million research grant could lead to life-saving antibiotics.READ MORE